BCYC
Price
$3.90
Change
-$0.08 (-2.01%)
Updated
Aug 14 closing price
Capitalization
272.97M
76 days until earnings call
Intraday BUY SELL Signals
LENZ
Price
$4.73
Change
+$0.13 (+2.83%)
Updated
Aug 14 closing price
Capitalization
148.93M
5 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCYC vs LENZ

BCYC vs LENZ Comparison Chart in %
View a ticker or compare two or three
VS
BCYC vs. LENZ commentary
Aug 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and LENZ is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 15, 2026
Stock price -- (BCYC: $3.98 vs. LENZ: $4.60)
Brand notoriety: BCYC and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 64% vs. LENZ: 135%
Market capitalization -- BCYC: $272.97M vs. LENZ: $148.93M
BCYC [@Biotechnology] is valued at $272.97M. LENZ’s [@Biotechnology] market capitalization is $148.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $128.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileLENZ’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • LENZ’s FA Score: 1 green, 4 red.
According to our system of comparison, both BCYC and LENZ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while LENZ’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 5 bearish.
  • LENZ’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LENZ is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а +0.25% price change this week, while LENZ (@Biotechnology) price change was -11.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.59%. For the same industry, the average monthly price growth was -1.35%, and the average quarterly price growth was +2889.08%.

Reported Earning Dates

BCYC is expected to report earnings on Oct 29, 2026.

LENZ is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (+0.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($273M) has a higher market cap than LENZ($149M). BCYC YTD gains are higher at: -43.785 vs. LENZ (-71.250). LENZ has higher annual earnings (EBITDA): -117.98M vs. BCYC (-183.2M). BCYC has more cash in the bank: 510M vs. LENZ (258M). LENZ has less debt than BCYC: LENZ (673K) vs BCYC (14.7M). BCYC has higher revenues than LENZ: BCYC (61.2M) vs LENZ (21M).
BCYCLENZBCYC / LENZ
Capitalization273M149M183%
EBITDA-183.2M-117.98M155%
Gain YTD-43.785-71.25061%
P/E RatioN/A48.03-
Revenue61.2M21M291%
Total Cash510M258M198%
Total Debt14.7M673K2,184%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
76
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
5

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCLENZ
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signal:
Gain/Loss:
LENZ
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX21.29N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
RYNVX210.15N/A
N/A
Rydex Nova Inv
FCCGX32.08N/A
N/A
Fidelity Advisor Small Cap Growth C
AALIX14.45N/A
N/A
Cavanal Hill Hedged Equity Income A
LAVVX18.58N/A
N/A
Lord Abbett Fundamental Equity R6

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with DNLI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-1.97%
DNLI - BCYC
48%
Loosely correlated
-1.78%
BHVN - BCYC
47%
Loosely correlated
+3.20%
PCVX - BCYC
47%
Loosely correlated
-1.32%
MGTX - BCYC
46%
Loosely correlated
-2.24%
NGNE - BCYC
45%
Loosely correlated
-3.65%
More

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with MLTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
-8.73%
MLTX - LENZ
37%
Loosely correlated
-4.24%
LKFT - LENZ
37%
Loosely correlated
+0.39%
CELC - LENZ
36%
Loosely correlated
-5.95%
BCYC - LENZ
35%
Loosely correlated
-1.97%
REPL - LENZ
34%
Loosely correlated
-0.33%
More